MeiraGTx Holdings plc (MGTX) shares dropped 12.89% to $9.80, down $1.45 on Thursday over the company's newly announced equity offering, and a strategic asset acquisition.
The stock is currently trading at $9.80, below its previous close of $11.25 on the Nasdaq. It opened at $9.55 and has traded in a range of $8.77 to $10.05 during the session, with volume reaching 838,979 shares compared to an average of 503,356 shares.
The company announced it will acquire full rights to bota-vec from Johnson & Johnson for the treatment of X-linked retinitis pigmentosa, while also pricing an offering of 11.1 million shares at $9.00 per share to raise approximately $100 million.
The 52-week range for the stock is $4.55 to $11.85.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.